Local pharmaceutical companies are obtaining the marketing approval for generic copies of Jardiance, an antidiabetic SGLT-2 inhibitor, one after another. The move is regarded as an early preparation to secure the Jardiance generic market when the patent of Jardiance expires in 2025.On Wednesday, the
Genencell said that the Ministry of Food and Drug Safety has approved the company’s investigational new drug (IND) application to conduct phase 2 and 3 clinical trials for ES16001, an oral Covid-19 treatment.Genencell explained that the ministry’s approval signals the official start of global clinic
Sotorasib and adagrasib are expected to compete with each other in the Kras G12C inhibitor market, which is regarded as a promising oncology field worldwide, industry officials said.Kras G12C is a mutation in multiple cancers, including lung, colorectal, and pancreatic cancers.On Tuesday, Novartis d
Viatris Korea will move out from the building of Pfizer Korea completely by the end of this year, and the two companies will reduce their workforce through voluntary retirement programs, according to industry officials.Pfizer Korea and Viatris Korea said they recently confirmed their plans to move t
GSK Korea said it has temporarily suspended the supply of eight GSK vaccines due to a misalignment in its technical documentation.The eight vaccines are Rotarix (rotavirus vaccine), Synflorix (pneumococcal vaccine), Menveo (meningococcal vaccine), Havrix (hepatitis A vaccine), Priorix (measles, mump
Huons Biopharma said Tuesday that it has signed an export contract with Haemato Pharm, a German-based pharmaceutical company, to exclusively supply Hutox, its botulinum toxin (BTX) product, to the European market.Under the accord, Huons Biopharma will supply its BTX product to Haemato Pharm for a de
Korean pharmaceutical and biotech companies said they would promote their latest pipelines and health technologies in Bio-Europe 2021, the largest biotech and healthcare event in Europe, from Oct. 25-28.As many countries, including Korea, have begun easing virus restrictions gradually, industry watc
The Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) selected Humedix to receive government support for facilities and machines to produce a Covid-19 vaccine.Humedix will get funding from the government to prepare equipment and facilities for producing a Rus
The Oxford University Innovation (OUI) Press Center said Hanmi Science CEO Lim Jong-yoon, the largest stakeholder of Cancer Rop, was appointed as a registered director of Oxford Vacmedix.Oxford Vacmedix, based at the Oxford Science Park, the U.K., is a biopharmaceutical firm spun out from the Univer
MDimune has agreed with China’s NeoCura Bio-Medical Technology (NeoCura), a company specializing in RNA therapeutics, to conduct collaborative studies of cell-derived vesicles (CDV)-based mRNA therapeutic cancer vaccines.Under the accord, the two companies will jointly seek opportunities of developi
Hanmi Pharmaceutical obtained approval for Esomezol Plus, a combination drug mixing a proton-pump inhibitor (PPI) with an antacid, heating the competition in the combo treatment market.On Friday, the Ministry of Food and Drug Safety granted the marketing license for Esomezol Plus Tab. 40/350mg as a
The mRNA vaccines against the Covid-19 pandemic have also shed light on the related technology as a next-generation vaccine for seasonal influenza. However, Korean companies remain cautious because of uncertain marketability, industry executives said Friday.Global pharmaceuticals, including Moderna,
Minority shareholders of biopharmaceutical companies, who had remained content with expressing simple discontent when problems arose, are beginning to change, according to industry executives.They form shareholder solidarity groups to call for managers to work out measures to bolster share prices an
Janssen’s Rybrevant (amivantamab), the first therapy for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, may obtain marketing approval in Korea, industry sources said.The Ministry of Food and Drug Safety is reviewing Janssen’s app
Legochem Bioscience said that it has signed a research collaboration and license option agreement to develop an antibody-drug conjugate (ADC) treatment with Antengene Biologics, a Chinese biopharmaceutical company.The two companies plan to discover ADC candidates using Antengene's antibodies and Leg
Boryung Pharmaceutical said that it has acquired all local rights, including sales and licensing, concerning Lilly's schizophrenia treatment Zyprexa (ingredient name: olanzapine).Zyprexa, launched in 1996, is the most prescribed treatment for schizophrenia.Hospitals use the drug to treat schizophren
Shinpoong Pharmaceutical said it registered the first patient for the domestic phase 3 trial of Pyramax (pyronaridine/artesunate), an oral drug for Covid-19 treatment.“At around 7 p.m. on Monday, we enrolled the first Korean patient for the phase 3 study at Sahmyook Medical Center,” an official at S
Merck Life Science, the life science arm of Merck KGaA in Darmstadt, Germany, celebrated the fifth anniversary of its M Lab Collaboration Center in Songdo, Incheon, on Thursday.The center is a non-GMP facility, equipped and designed to recreate the manufacturing environment, evaluate and resolve pro
SK Plasma, a subsidiary of SK Discovery, said that it has won the national bid to supply blood products to Singapore."This is the first time a Korean pharmaceutical company has won a national bid for blood products in Singapore," the company said. "Until now, multinational pharmaceutical companies h
CancerRop, which specializes in genetic analysis and molecular diagnostics, said Thursday that it signed a 3 billion won ($2.55-million) contract with COREE Company to collaborate in immune cell profiling to establish data for developing vaccines.Under the accord, CancerRop will also cooperate with